|
|
 |
PRESS RELEASE:
Millions of
Dollars Redirected HepCop
has publicly denounced the National Institutes of Health (NIH) for
spending millions of dollars budgeted for Hepatitis C
(HCV) on other research agendas. |
National Center for
Complementary and Alternative Medicine
NCCAM
|
Description |
Project
Number |
Name |
Cost |
Project Title |
|
Clinical Trial Chronic Liver Disease |
5U01AT003573-03 |
RAY, RATNA |
$255,596
|
A phase I/II
trial of silymarin for chronic liver diseases |
| |
5U01AT003566-03 |
BELLE, STEVEN |
$393,253
|
Phase I/II Trials
of Silymarin for Chronic Liver Diseases Data Coordinating Cente |
| |
5U01AT003560-03 |
FRIEDMAN, SAMUEL |
$273,536
|
A phase I/II
randomized, placebo controlled trial of silymarin for hepatitis C |
| |
5U01AT003571-03 |
AFDHAL, NEZAM |
$275,862
|
Clinical Center
for Phase I/II trials of Silymarin in Chronic Liver Disease |
|
HCV
Based Research |
1R21AT002895-01A2 |
PILLAI, SATISH |
$247,685
|
Mechanisms of
Action of Silymarin for Hepatitis C |
|
Liver Disease Research |
1R21AT003892-01A2 |
HEATON, ROBERT |
$147,500
|
CAM Herbal
Cocktails for Boosting Antioxident Activity to Treat Liver Disease |
|
Total NCCAM NIH Funding
$1,593,432
|
|
Source: National Institutes of Health Research Portfolio
Online Reporting Tool (RePORT) Reports,
Data and Analyses of NIH Research Activities
Retrieved on March 18, 2009
http://report.nih.gov/rcdc/categories/ProjectSearch.aspx?FY=2008&DCat=Hepatitis+-+C
Permission is granted to use all information from this website
in pursuit of ending NIH's "Trans-Plan" discriminatory practices against HCV
research funding allocations.
Please Credit: HCVets.com Educational Website &
Support Forums for Military Related HCV Exposures.
Contact HepCop
Email:
Staff
|
